Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001209191-22-060975

See Remarks sold 312 shares at $10.87 ($3,391)

  • See Remarks acquired 31,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Scalzo Richard William See Remarks 2022-12-09 Grant or award +31,000 56,495 D
Scalzo Richard William See Remarks 2022-12-12 Sale −312 $10.87 $3,391 56,183 D
Derivatives
Scalzo Richard William See Remarks 2022-12-09 Grant or award · Stock Option (right to buy) +45,000 45,000 D
Open-market sales · 312 sh · avg $10.87 · $3,391
Loading xslF345X03/doc4.xml…